Elekta Value Stock - Dividend - Research Selection
Market price: 94,54 SEK
Elekta AB Series B Fundamental data and company key figures of the share
|Annual reports in SEK|
|Net operating cash flow||2.551.000.000|
|Free cash flow||2.384.000.000|
|Liabilities & Shareholders equity||24.844.000.000|
|Diluted shares outstanding||382.083.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||4.073.449.472,00 USD|
|Indices||STOXX EUROPE 600|
|Sectors||Health Care Supplies|
|Raw Data Source||IFRS in Millionen SEK|
|Stock Split||2012-09-12,4.000000/1.000000; 2005-10-17,3.000000/1.000000|
Description of the company
Elekta AB develops, manufactures and sells treatment planning systems for neurosurgery and radiation therapy, including stereotactic radiation surgery and brachytherapy. The company's installed base with more than 4,500 platforms and software is used in more than 6,000 hospitals worldwide. The company's sales are evenly distributed across the regions, with North and South America accounting for 31%; Europe, the Middle East and Africa account for 38%; and Asia Pacific contributed the rest.